Index Entries - The Covid Index

Search Index Entries

2178 Results

Title	Publication
Risk of Coronavirus Disease 2019 (COVID-19) among those up-to-date and not up-to-date on COVID-19 vaccination by US CDC criteria	PLOS One
Risk of heavy menstrual bleeding following COVID-19 vaccination: A nationwide case-control study	Vaccine
Risk of Hospitalization, severe disease, and mortality due to COVID-19 and PIMS-TS in children with SARS -CoV-2 infection in Germany
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden	The Lancet
Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex	Circulation
Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England	PLOS Medicine
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination	Vaccine
Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis	BMJ Open
Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods	Pharmcoepidemiology & Drug Safety
Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein	PLOS One
Risk of SARS-CoV-2 infection and hospitalization in individuals with natural, vaccine-induced and hybrid immunity: a retrospective population-based cohort study from Estonia	Scientific Reports
Risk of severe COVID-19 infection among adults with prior exposure to children
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study	BMJ (British Medical Journal)
Risk stratification for future cardiac arrest after COVID-19 vaccination	World Journal of Cardiology
Risks of Covid-19 face masks to wildlife: Present and future research needs	Science of the Total Environment
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection	Nature Medicine
RNA "Vaccines" in Your Food	Dr. Tenpenny's Eye On The Evidence (substack)
RNA Pseudouridylation in Physiology and Medicine: For Better and for Worse	Genes
Roadmap for the Implementation of Actions by the European Commission based on the Commission Communication and the Council Recommendation on Strengthening Cooperation against Vaccine Preventable Diseases
Robust neutralizing antibodies to SARS-CoV-2 infection persist for months	Science
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection	Nature Immunology
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19	Cell
Rochelle Walensky on the risk of COVID-19 vaccines for 12-17 year olds	Good Morning America
Role of hydroxychloroquine in multidrug treatment of COVID-19	Reviews in Cardiovascular Medicine
Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study	PLOS One
Rush to Use Ventilators Killed Thousands of COVID Patients	The Defender
S2 of SARS-2 spike buggers up p53	Unacceptable Jessica
S2 subunit of SARS-nCoV-2 interacts with tumor suppressor protein p53 and BRCA: an in silico study	Translational Oncology
Sacrifice: How the Deadliest Vaccine in History Targeted the Most Vulnerable
Safe and Effective: A Second Opinion
Safe Nanoparticles: Are We There Yet?	International Journal of Molecular Sciences
Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review	Archives of Academic Emergency Medicine
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months	New England Journal of Medicine (NEJM)
Safety and Health Guidance: COVID-19 Infection Prevention for Logistics Employers and Employees
Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data	Human Vaccines & Immunotherapeutics
Safety of COVID-19 Vaccines: Spotlight on Neurological Complications	Life journal
Safety of mRNA Vaccines Administered During the First Twenty-Four Months of the International COVID-19 Vaccination Program	International Journal of Vaccine Theory, Practice, and Research
Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting	New England Journal of Medicine (NEJM)
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry	Annals of the Rheumatic Diseases
Safety Profiles of mRNA COVID-19 Vaccines Using World Health Organization Global Scale Database (VigiBase): A Latent Class Analysis	Infectious Diseases and Therapy
Safety Signals for COVID Vaccines Are Loud and Clear. Why Is Nobody Listening?	Children's Health Defense
Same Excess Death Patterns in Multiple Data Sets after mRNA Vaccine Rollouts	Brownstone Journal
SARS-CoV-2 and the Vaccination Hype	International Journal of Vaccine Theory, Practice, and Research
SARS-CoV-2 antibodies persist up to 12 months after natural infection in healthy employees working in non-medical contact-intensive professions	International Journal of Infectious Diseases
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy	eClinical Medicine
SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19	Journal of Hematology & Oncology
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor	Cell
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity	The Lancet
SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans	Nature

Page 33 of 44